Article Details
Retrieved on: 2025-05-02 20:33:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's lead programs –VERVE-102, VERVE-201, and VERVE-301 – target the three cholesterol drivers of atherosclerosis: LDL-C, triglycerides, and ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here